The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Parkin and PINK1 functions in oxidative stress and neurodegeneration
Open accessAbstract
Loss-of-function mutations in the genes encoding Parkin and PINK1 are causally linked to autosomal recessive Parkinson’s disease (PD). Parkin, an E3 ubiquitin ligase, and PINK1, a mitochondrial-targeted kinase, function together in a common pathway to remove dysfunctional mitochondria by autophagy. Presumably, deficiency for Parkin or PINK1 impairs mitochondrial autophagy and thereby increases oxidative stress due to the accumulation of dysfunctional mitochondria that release reactive oxygen species. Parkin and PINK1 likely have additional functions that may be relevant to the mechanisms by which mutations in these genes cause neurodegeneration, such as regulating inflammation, apoptosis, or dendritic morphogenesis. Here we briefly review what is known about functions of Parkin and PINK1 related to oxidative stress and neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 4×
“Loss-of-function mutations in Parkin account for about 50% of all cases of early onset PD (Kitada et al. 1998; Lucking et al. 2000).”
BackgroundInfluentialParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 3×
“PINK1 is a mitochondrial kinase that accumulates on the surface of defective mitochondria and recruits Parkin to promote selective degradation of dysfunctional mitochondria (Narendra et al. 2008; Matsuda et al. 2010).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944 · cited 1×
“…by treating cells with ionophores, such as CCCP or valinomycin, causes PINK1 to accumulate on the outer mitochondrial membrane and to recruit Parkin to selectively target dysfunctional mitochondria for degradation by autophagy (Narendra et al. 2008; Matsuda et al. 2010; Narendra et al. 2010).”
BackgroundPINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 1×
“…mitochondrial outer membrane proteins such as VDAC1, Mfn1/2, Miro, Hexokinase I, CISD1, and TOMM20 (Weihofen et al. 2009; Gegg et al. 2010; Geisler et al. 2010; Poole et al. 2010; Ziviani et al. 2010; Chan et al. 2011; Glauser et al. 2011; Kane and Youle 2011; Rakovic et al. 2011; Wang et…”
BackgroundThe ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 3×
“Parkin has been demonstrated to bind to several E2 ubiquitin conjugating proteins including UbcH7, UbcH8, and a UbcH13/Uev1a heterodimer that is thought to be responsible for the catalysis of K63-linked ubiquitin chains (Shimura et al. 2000; Zhang et al. 2000; Olzmann et al. 2007).”
BackgroundMatsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969 · cited 2×
“PINK1 is a mitochondrial kinase that accumulates on the surface of defective mitochondria and recruits Parkin to promote selective degradation of dysfunctional mitochondria (Narendra et al. 2008; Matsuda et al. 2010).”
BackgroundDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 16×
“Rat Knockout Yes Yes ND1 Dave et al. 2014 PINK1 (PARK6) Drosophila Knockout Yes ND1 Park et al. 2006, Clark et al. 2006 Mouse Knockout No Yes Yes Kitada et al. 2007, Gautier et al. 2008, Gispert et al. 2009, Akundi et al. 2011.”
BackgroundInfluentialMitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 8×
“Rat Knockout Yes Yes ND1 Dave et al. 2014 PINK1 (PARK6) Drosophila Knockout Yes ND1 Park et al. 2006, Clark et al. 2006 Mouse Knockout No Yes Yes Kitada et al. 2007, Gautier et al. 2008, Gispert et al. 2009, Akundi et al. 2011.”
BackgroundInfluentialZhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Oxidative stress and the pathogenesis of Parkinson's disease
Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913 · cited 6×
“Rat Knockout Yes Yes ND1 Dave et al. 2014 PINK1 (PARK6) Drosophila Knockout Yes ND1 Park et al. 2006, Clark et al. 2006 Mouse Knockout No Yes Yes Kitada et al. 2007, Gautier et al. 2008, Gispert et al. 2009, Akundi et al. 2011.”
BackgroundResultSelf-citationGegg, M. E., Cooper, J. M., Chau, K.-Y., Rojo, M., Schapira, A. H. V., & Taanman, J.-W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq419 · Cited by 910 · cited 1×
“…various proteins including mitochondrial outer membrane proteins such as VDAC1, Mfn1/2, Miro, Hexokinase I, CISD1, and TOMM20 (Weihofen et al. 2009; Gegg et al. 2010; Geisler et al. 2010; Poole et al. 2010; Ziviani et al. 2010; Chan et al. 2011; Glauser et al. 2011; Kane and Youle 2011; Rakovic et…”
BackgroundMitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
Bingol, B., Tea, J. S., Phu, L., Reichelt, M., Bakalarski, C. E., Song, Q., Foreman, O., Kirkpatrick, D. S., & Sheng, M. (2014) · Nature · doi:10.1038/nature13418 · Cited by 855 · cited 1×
“The deubiquitinating enzymes (DUBs) USP30 and USP15 were recently found to oppose Parkin/PINK1 mediated mitophagy, suggesting that inhibitors of these DUBs would be good candidates for drug design (Bingol et al. 2014; Cornelissen et al. 2014).”
BackgroundParkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M. S., Hofmann, K., Alessi, D. R., Knebel, A., Trost, M., & Muqit, M. M. K. (2014) · Biochemical Journal · doi:10.1042/bj20140334 · Cited by 806 · cited 5×
“…phosphorylating ubiquitin (Kondapalli et al. 2012; Shiba-Fukushima et al. 2012; Caulfield et al. 2014; Kane et al. 2014; Kazlauskaite et al. 2014a; Kazlauskaite et al. 2014b; Koyano et al. 2014; Ordureau et al. 2014; Sauve and Gehring 2014; Shiba-Fukushima et al. 2014; Caulfield et al. 2015;…”
BackgroundMethodInfluentialYang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W., Yang, L., Beal, M. F., Vogel, H., & Lu, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602493103 · Cited by 798
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582 · cited 2×
“It is noteworthy that Parkin inhibits the mitochondrial recruitment of Rab9 and Sorting nexin 9, which are required for the formation of MDVs and mitochondrial autophagy (Matheoud et al. 2016).”
BackgroundShiba-Fukushima, K., Imai, Y., Yoshida, S., Ishihama, Y., Kanao, T., Sato, S., & Hattori, N. (2012) · Scientific Reports · doi:10.1038/srep01002 · Cited by 577 · cited 3×
“…for recruiting Parkin from the cytosol to the mitochondrial outer membrane and as enhancers of Parkin’s E3 ligase activity (Kondapalli et al. 2012; Shiba-Fukushima et al. 2012; Caulfield et al. 2014; Kane et al. 2014; Kazlauskaite et al. 2014a; Kazlauskaite et al. 2014b; Koyano et al. 2014;…”
BackgroundParkin-deficient mice are not a robust model of parkinsonism
Perez, F. A., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409598102 · Cited by 477
Mitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455
The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway
Poole, A. C., Thomas, R. E., Yu, S., Vincow, E. S., & Pallanck, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010054 · Cited by 440 · cited 1×
“…outer membrane proteins such as VDAC1, Mfn1/2, Miro, Hexokinase I, CISD1, and TOMM20 (Weihofen et al. 2009; Gegg et al. 2010; Geisler et al. 2010; Poole et al. 2010; Ziviani et al. 2010; Chan et al. 2011; Glauser et al. 2011; Kane and Youle 2011; Rakovic et al. 2011; Wang et al. 2011; Okatsu et…”
BackgroundUSP8 regulates mitophagy by removing K6‐linked ubiquitin conjugates from parkin
Durcan, T. M., Tang, M. Y., Pérusse, J. R., Dashti, E. A., Aguileta, M. A., McLelland, G., Gros, P., Shaler, T. A., Faubert, D., Coulombe, B., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201489729 · Cited by 375 · cited 2×
“In contrast, USP8 promotes Parkin mediated mitophagy and agonists to USP8 could be developed as potential therapeutics (Durcan et al. 2014).”
BackgroundModulation of inflammation by autophagy: Consequences for human disease
Netea-Maier, R. T., Plantinga, T. S., van de Veerdonk, F. L., Smit, J. W., & Netea, M. G. (2016) · Autophagy · doi:10.1080/15548627.2015.1071759 · Cited by 349
BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., & MARSDEN, C. D. (1992) · Brain · doi:10.1093/brain/115.2.333 · Cited by 346 · cited 1×
“…damaged subunits of mitochondrial complex I are increased in PD brains (Keeney et al. 2006) and impaired complex I activity has been observed in multiple tissues and peripheral blood leukocytes from PD patients (Mann et al. 1992; Albers and Beal 2000; Muftuoglu et al. 2004; Schapira 2008).”
BackgroundAutoregulation of Parkin activity through its ubiquitin‐like domain
Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S., & Walden, H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.204 · Cited by 339 · cited 1×
“Furthermore, deletion of the Ubl domain actually increases Parkin auto-ubiquitination, consistent with the Ubl domain functioning as a constitutive inhibitor of Parkin’s E3 ligase activity (Chaugule et al. 2011).”
BackgroundOrdureau, A., Heo, J.-M., Duda, D. M., Paulo, J. A., Olszewski, J. L., Yanishevski, D., Rinehart, J., Schulman, B. A., & Harper, J. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506593112 · Cited by 310
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
Jiang, H., Ren, Y., Zhao, J., & Feng, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh180 · Cited by 239 · cited 1×
“…such as mitochondrial stress, endoplasmic reticulum stress, excitotoxicity, and proteotoxic stress (Imai et al. 2000; Petrucelli et al. 2002; Darios et al. 2003; Staropoli et al. 2003; Higashi et al. 2004; Jiang et al. 2004; Muqit et al. 2004; Yang et al. 2005; Rosen et al. 2006; Fett et al. 2010).”
BackgroundParkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1
Glauser, L., Sonnay, S., Stafa, K., & Moore, D. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07318.x · Cited by 230
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · cited 1×
“Many of the same proteins that govern autophagy and mitophagy, including Parkin and PINK1, are also involved in adaptive and innate immunity (Dzamko et al. 2015; Netea-Maier et al. 2015).”
Background(Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation
Fiesel, F. C., Ando, M., Hudec, R., Hill, A. R., Castanedes‐Casey, M., Caulfield, T. R., Moussaud‐Lamodière, E. L., Stankowski, J. N., Bauer, P. O., Lorenzo‐Betancor, O., et al. (2015) · The EMBO Reports · doi:10.15252/embr.201540514 · Cited by 185 · cited 4×
“…Kazlauskaite et al. 2014b; Koyano et al. 2014; Ordureau 8 et al. 2014; Sauve and Gehring 2014; Shiba-Fukushima et al. 2014; Caulfield et al. 2015; Fiesel et al. 2015a; Kazlauskaite et al. 2015; Okatsu et al. 2015a; Okatsu et al. 2015b; Ordureau et al. 2015a; Ordureau et al. 2015b; Wauer et al.…”
BackgroundInfluentialKubli, D. A., Cortez, M. Q., Moyzis, A. G., Najor, R. H., Lee, Y., & Gustafsson, Å. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130707 · Cited by 102
Fiesel, F. C., Caulfield, T. R., Moussaud-Lamodière, E. L., Ogaki, K., Dourado, D. F. A. R., Flores, S. C., Ross, O. A., & Springer, W. (2015) · Human Mutation · doi:10.1002/humu.22808 · Cited by 89 · cited 4×
“…Kazlauskaite et al. 2014b; Koyano et al. 2014; Ordureau 8 et al. 2014; Sauve and Gehring 2014; Shiba-Fukushima et al. 2014; Caulfield et al. 2015; Fiesel et al. 2015a; Kazlauskaite et al. 2015; Okatsu et al. 2015a; Okatsu et al. 2015b; Ordureau et al. 2015a; Ordureau et al. 2015b; Wauer et al.…”
BackgroundInfluentialKumaran, R., & Cookson, M. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv236 · Cited by 86 · cited 1×
“Most PD cases are sporadic, but the recent identification of genes with mutations linked to familial forms of PD provides important clues that could help determine the causes of both familial and idiopathic PD, and could lead to the development of more effective therapies (Kumaran and Cookson 2015).”
BackgroundInhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin
Charan, R. A., Johnson, B. N., Zaganelli, S., Nardozzi, J. D., & LaVoie, M. J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.278 · Cited by 67 · cited 1×
“…and distinct functions include Parkin regulation of mitochondrial cytochrome c release, BAX translocation to mitochondria, and apoptosis (Berger et al. 2009; Johnson et al. 2012a; Johnson et al. 2012b; Charan et al. 2014), and PINK1 regulation of neuronal dendritic morphology (Dagda et al. 2014).”
BackgroundExpression of PINK1 mRNA in human and rodent brain and in Parkinson's disease
Blackinton, J. G., Anvret, A., Beilina, A., Olson, L., Cookson, M. R., & Galter, D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.056 · Cited by 59
Cited by
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K.-H., & Chen, C.-M. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 341
The mitochondrial permeability transition: Nexus of aging, disease and longevity
Rottenberg, H., & Hoek, J. B. (2021) · Cells · doi:10.3390/cells10010079 · Cited by 94
Qi, H., Shen, D., Jiang, C., Wang, H., & Chang, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135493 · Cited by 76
Xu, J., Chen, P., Zhao, G., Wei, S., Li, Q., Guo, C., Cao, Q., Wu, X., & Di, G. (2022) · Current Eye Research · doi:10.1080/02713683.2021.2022163 · Cited by 26
Metadata
- Authors
- Barodia, S. K., Creed, R. B., & Goldberg, M. S.
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 133
- Pages
- 51-59
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W2563592935
- Cited by
- 167
- References
- 39
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.